Clinical Trial Update: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of guadecitabine and durvalumab in advanced cholangiocarcinoma, gallbladder cancer, hepatocellular carcinoma, and pancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Guadecitabine (guadecitabine)

Snippet

Sponsor: University of Southern California | Conditions: Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type | Phase 1 | Status: ACTIVE_NOT_RECRUITING